- Home
- DRTS vs NHS Comparison
DRTS vs NHS Comparison
Compare DRTS & NHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRTS
- NHS
- Stock Information
- Founded
- DRTS 2015
- NHS 2003
- Country
- DRTS Israel
- NHS United States
- Employees
- DRTS N/A
- NHS N/A
- Industry
- DRTS Medical/Dental Instruments
- NHS Trusts Except Educational Religious and Charitable
- Sector
- DRTS Health Care
- NHS Finance
- Exchange
- DRTS Nasdaq
- NHS Nasdaq
- Market Cap
- DRTS 262.6M
- NHS 221.6M
- IPO Year
- DRTS N/A
- NHS N/A
- Fundamental
- Price
- DRTS $2.96
- NHS $7.47
- Analyst Decision
- DRTS Strong Buy
- NHS
- Analyst Count
- DRTS 2
- NHS 0
- Target Price
- DRTS $8.00
- NHS N/A
- AVG Volume (30 Days)
- DRTS 42.3K
- NHS 111.8K
- Earning Date
- DRTS 08-13-2025
- NHS 01-01-0001
- Dividend Yield
- DRTS N/A
- NHS 13.44%
- EPS Growth
- DRTS N/A
- NHS N/A
- EPS
- DRTS N/A
- NHS N/A
- Revenue
- DRTS N/A
- NHS N/A
- Revenue This Year
- DRTS N/A
- NHS N/A
- Revenue Next Year
- DRTS N/A
- NHS N/A
- P/E Ratio
- DRTS N/A
- NHS N/A
- Revenue Growth
- DRTS N/A
- NHS N/A
- 52 Week Low
- DRTS $1.75
- NHS $6.95
- 52 Week High
- DRTS $4.39
- NHS $9.17
- Technical
- Relative Strength Index (RSI)
- DRTS 51.12
- NHS 41.38
- Support Level
- DRTS $2.85
- NHS $7.37
- Resistance Level
- DRTS $3.04
- NHS $7.60
- Average True Range (ATR)
- DRTS 0.17
- NHS 0.07
- MACD
- DRTS -0.02
- NHS -0.02
- Stochastic Oscillator
- DRTS 31.43
- NHS 14.71
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.
About NHS Neuberger Berman High Yield Strategies Fund
Neuberger Berman High Yield Strategies Fund is closed-end management investment company. It seeks to achieve its investment objective by investing, under normal market conditions, a majority of its total assets in high yield debt securities of U.S. and foreign issuers.